4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001209191-22-012399
Director bought 151,472 shares at an average $1.45 ($219,667)
From the SEC's structured data for this filing
Trades in this filing
MOTT DAVID M · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-18 | Purchase : show line 1 in the form | +50,398 | $1.30 | $65,517 | 128,150 | D |
| 2022-02-22 | Purchase : show line 2 in the form | +65,817 | $1.56 | $102,675 | 193,967 | D |
| 2022-02-23 | Purchase : show line 3 in the form | +35,257 | $1.46 | $51,475 | 229,224 | D |
| Open-market purchases · 151,472 sh · avg $1.45 · $219,667 | ||||||
Loading xslF345X03/doc4.xml…